TR199802665T2 - Piperidin asetik asit türevleri ve bunlarin trombotik hastaliklarin tedavisinde kullanimi. - Google Patents

Piperidin asetik asit türevleri ve bunlarin trombotik hastaliklarin tedavisinde kullanimi.

Info

Publication number
TR199802665T2
TR199802665T2 TR1998/02665T TR9802665T TR199802665T2 TR 199802665 T2 TR199802665 T2 TR 199802665T2 TR 1998/02665 T TR1998/02665 T TR 1998/02665T TR 9802665 T TR9802665 T TR 9802665T TR 199802665 T2 TR199802665 T2 TR 199802665T2
Authority
TR
Turkey
Prior art keywords
treatment
acetic acid
thrombotic diseases
acid derivatives
piperidine acetic
Prior art date
Application number
TR1998/02665T
Other languages
English (en)
Inventor
George Allen David
David Eldred Colin
David Judkins Brian
Leonard Mitchell William
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR199802665T2 publication Critical patent/TR199802665T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bulus, formül (I)'in bilesikleri veya onun bir tuzu, solvati veya fizyolojik bakimdan islevsel bir türevi ile ilgilidir, sözkonusu formülde X, ya CH2-CH2'yi, ya da CH=CH'i; Y, grup (a) veya grup (b) 'yi R0, SO2Me'yi veya CONH2'yi ve R1, SO2ME'yi temsil etmektedir. Bulus, ayrica, bunlarin hazirlanmasi için yöntemlerle, bu tür bilesikleri içeren farmasötik bilesimlerle ve bunlarin tipta özellikle trombotik hastaliklarin tedavisinde kullanimiyla ilgilidir.
TR1998/02665T 1996-06-21 1997-06-19 Piperidin asetik asit türevleri ve bunlarin trombotik hastaliklarin tedavisinde kullanimi. TR199802665T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds

Publications (1)

Publication Number Publication Date
TR199802665T2 true TR199802665T2 (tr) 1999-03-22

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/02665T TR199802665T2 (tr) 1996-06-21 1997-06-19 Piperidin asetik asit türevleri ve bunlarin trombotik hastaliklarin tedavisinde kullanimi.

Country Status (17)

Country Link
EP (1) EP0912555A1 (tr)
JP (1) JP2000512648A (tr)
KR (1) KR20000022041A (tr)
AP (1) AP9801417A0 (tr)
AR (1) AR008245A1 (tr)
AU (1) AU3261197A (tr)
BR (1) BR9709930A (tr)
CA (1) CA2258753A1 (tr)
CZ (1) CZ424698A3 (tr)
EA (1) EA199801015A1 (tr)
ID (1) ID17052A (tr)
IL (1) IL127464A0 (tr)
IS (1) IS4924A (tr)
NO (1) NO985974L (tr)
PL (1) PL330797A1 (tr)
TR (1) TR199802665T2 (tr)
WO (1) WO1997049699A1 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
US7064215B2 (en) 2001-07-03 2006-06-20 Chiron Corporation Indazole benzimidazole compounds
TW200401641A (en) 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
WO2004074243A2 (en) * 2003-02-14 2004-09-02 Wyeth Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
WO2007117413A1 (en) 2006-04-05 2007-10-18 Wyeth Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
CN101578265B (zh) 2007-01-10 2013-05-08 霍夫曼-拉罗奇有限公司 用作糜蛋白酶抑制剂的磺酰胺衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH07501063A (ja) * 1991-11-14 1995-02-02 グラクソ、グループ、リミテッド フィブリノーゲン依存性血小板凝集阻害剤としてのピペリジン酢酸誘導体
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
JP2000512648A (ja) 2000-09-26
IS4924A (is) 1998-12-15
ID17052A (id) 1997-12-04
CZ424698A3 (cs) 1999-05-12
CA2258753A1 (en) 1997-12-31
IL127464A0 (en) 1999-10-28
NO985974D0 (no) 1998-12-18
AU3261197A (en) 1998-01-14
AR008245A1 (es) 1999-12-29
EA199801015A1 (ru) 1999-08-26
AP9801417A0 (en) 1998-12-31
KR20000022041A (ko) 2000-04-25
EP0912555A1 (en) 1999-05-06
WO1997049699A1 (en) 1997-12-31
PL330797A1 (en) 1999-06-07
NO985974L (no) 1999-02-17
BR9709930A (pt) 1999-08-10

Similar Documents

Publication Publication Date Title
DE69912313D1 (de) Colchinolderivate als gefässschädigende mittel
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
TR200000022T2 (tr) 3-ya da 4-eşlenimli 4-(aminometil)-piperidin türevlerinin tek halkalı gastrokinetik benzamidleri.
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
NO963053L (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
UA44254C2 (uk) Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
ATE192153T1 (de) Amino-imidazo (4,5-c) chinoline
TR200001645T2 (tr) Retinoyik asit taklidi anilürler.
FI941987A (fi) Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset
HUP9702345A2 (hu) 3-Hidroxi-piridin-2-karbonsav-amid-észter-származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE250034T1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
HUP0001164A2 (hu) PF1022-ciklodepszipeptid-származékok
DE60317039D1 (de) Peptidborsäuren und deren Verwendung in der Herstellung von Salzen derselben
HUP0003571A2 (hu) 6,9-Hídkötésű eritromicin-származékok
TR200103624T2 (tr) Amof bileşikler ve bunların farmasötik bileşimleri.
ATE78812T1 (de) Diarylverbindungen als antiatherosklerotische mittel.
HUP0003577A2 (hu) Tetrahidro-gamma-karbolinok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0202803A2 (en) Titanium derived compounds, preparation and use thereof
TR199801229T2 (tr) ''Metalopeptidaz inhibisyon aktivitesini havi tiol türevleri
TR199802665T2 (tr) Piperidin asetik asit türevleri ve bunlarin trombotik hastaliklarin tedavisinde kullanimi.
DE60019086D1 (de) Zusammensetzungen zur behandlung von hautkrankheiten
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
DE69819539D1 (de) Antithrombotische mittel
TR200100896T2 (tr) İkameli propanol türevleri, imalat yöntemleri, bileşimleri içeren ilaçlar, kullanımları